Physician profile
Patrick Yu
NPI 1811330830
$8,963.37
in general payments reported to CMS, 2019-2025
34 companies · $1,281 in 2025
The $1,281 reported for 2025 was more than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,542 · 2020: $854 · 2021: $1,523 · 2022: $1,011 · 2023: $317 · 2024: $435 · 2025: $1,281.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,034.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,033.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $3,925.43 | 2019-2020 | |
| Silk Road Medical, INC. | $1,207.41 | 2020-2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| W. L. Gore & Associates, INC. | $753.25 | 2022 | |
| Endologix LLC | $568.03 | 2025 | Afx2 Bifurcated Endograft System |
| Cardiovascular Systems INC. | $458.95 | 2020-2022 | |
| Terumo Medical Corporation | $210.72 | 2021 | |
| Penumbra, INC. | $206.06 | 2022-2023 | Indigo System, Penumbra System |
| Boston Scientific Corporation | $191.09 | 2021-2025 | Varithena Administration Pack, Enroute Transcarotid Stent, Eluvia |
| Medtronic, INC. | $166.59 | 2021-2025 | Ligasure, Venaseal, Closurefast |
| Stryker Corporation | $148.92 | 2024-2025 | Actishield Cf, Flowtriever, Flowtriever Catheter, S |
| Bard Peripheral Vascular, INC. | $125.74 | 2021-2025 | Venovo, Fluency Endovascular Stent Graft |
| Laminate Medical Technologies INC. | $121.20 | 2024 | Vasq External Support |
| Innovation Technologies INC | $117.72 | 2025 | Irrisept |
| Inari Medical, INC. | $68.93 | 2021-2022 | |
| Cook Medical LLC | $65.02 | 2024-2025 | Zenith Spiral-Z, Zilver Ptx |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Reflow Medical INC | $60.23 | 2024-2025 | |
| Becton, Dickinson and Company | $59.03 | 2020-2021 | |
| Lemaitre Vascular, INC. | $58.16 | 2021-2024 | Artegraft Vascular Graft, Pruitt F3 Carotid Shunt |
| Surmodics, INC. | $56.54 | 2025 | Sublime 014 Rx Pta Balloon Dilatation Catheter, Pounce Thrombectomy, Pounce Thrombectomy System |
| Abbott Laboratories | $54.90 | 2023 | Diamondback Peripheral |
| Smith+Nephew, INC. | $46.39 | 2022-2023 | Collagenase Santyl, Regranex |
| Angiodynamics, INC. | $45.22 | 2024-2025 | Auryon Laser System 100-120 Vac |
| Solventum Corporation | $36.86 | 2025 | Prevena, V.A.C. Veraflo Cleanse Choice |
| Janssen Pharmaceuticals, INC | $35.83 | 2021 | |
| Covidien Lp | $25.63 | 2020 | |
| Cagent Vascular INC | $23.35 | 2025 | Serrantor |
| Neuros Medical, INC. | $18.24 | 2025 | Altius |
| Ethicon US, LLC | $17.63 | 2025 | Harmonic, Echelon Circular |
| E.R. Squibb & Sons, L.L.C. | $17.44 | 2025 | Eliquis |
| Bolton Medical INC | $16.32 | 2023 | Treo Abdominal Stent-Graft System |
| Hologic Sales and Service, LLC | $16.19 | 2024 | Coolseal Generator |
| Cordis US Corp. | $14.95 | 2024 | Mynxgrip |
| Pfizer INC. | $13.76 | 2020 | |
| Merit Medical Systems INC | $11.64 | 2024 | Savi Scout, Savi Brachy |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Yu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.